Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02597478 · ClinicalTrials.gov registry record · Phase 2
Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT02597478: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT02597478 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02597478, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if fentanyl can help shortness of breath in cancer patients. Researchers also want to learn if the study drug can help to improve your physical function.
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Phone Call
- DRUG Fentanyl Sublingual Spray
- PROCEDURE Shuttle Walk Test
- BEHAVIORAL Mental Ability Tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01-04 |
| Est. Completion | 2021-01-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02597478
The ClinicalTrials.gov registry entry for NCT02597478 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Questionnaires is the first listed.
NCT02597478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02597478 about?
NCT02597478 is a clinical study titled "Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea". The goal of this clinical research study is to learn if fentanyl can help shortness of breath in cancer patients. Researchers also want to learn if the study drug can help to improve your physical function.
What is the current status of trial NCT02597478?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2016-01-04. Estimated completion is 2021-01-27.
What interventions are being tested in trial NCT02597478?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Phone Call (BEHAVIORAL), Fentanyl Sublingual Spray (DRUG), Shuttle Walk Test (PROCEDURE), Mental Ability Tests (BEHAVIORAL).
Who is sponsoring clinical trial NCT02597478?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.